Clinical Practice Guidelines for the Management of Sporotrichosis: 2007 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases·
- DOI
- 10.1086/522765
- PMID
- 17968818
- PMCID
- —
- OpenAlex
- W2155053310
- Study type
- Guideline
- Publisher
- Oxford University Press (OUP)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Standardized clinical practice guidelines support consistent, evidence-informed management of sporotrichosis across diverse healthcare settings and patient populations.
Structured evidence summary
Research question
These guidelines address the clinical management of sporotrichosis across multiple disease presentations, including lymphocutaneous, cutaneous, pulmonary, osteoarticular, meningeal, and disseminated forms, as well as treatment in special populations.
Study design
Expert panel consensus guideline developed by the Infectious Diseases Society of America, representing a 2007 update to previous 2000 guidance.
Population and setting
The guidance targets patients with sporotrichosis and is intended for use by internists, pediatricians, family practitioners, and dermatologists. Special populations addressed include pregnant women and children.
Main findings
The guidelines provide evidence-based recommendations for managing multiple clinical forms of sporotrichosis and offer treatment guidance tailored to pregnant women and pediatric patients.
Public-health relevance
Standardized clinical practice guidelines support consistent, evidence-informed management of sporotrichosis across diverse healthcare settings and patient populations.
Important limitations
This summary relies solely on the supplied abstract and bibliographic metadata. Full assessment of evidence quality, strength of recommendations, and applicability requires review of the complete guideline document.
GIDS interpretation
This guideline would be discoverable through queries for sporotrichosis clinical management, antifungal treatment protocols, or health policy related to fungal infections in the United States. It represents authoritative consensus rather than primary surveillance data.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 10 auditable classifier relationships to diseases, places, topics, and study design.